Townsquare Capital LLC Neuronetics, Inc. Transaction History

Townsquare Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$1.05 - $2.9 $14,445 - $39,898	-13,758 Reduced 49.38%	14,104 $40,000
Q3 2023 Nov 15, 2023	SELL	$1.29 - $2.22 $63,911 - $109,987	-49,544 Reduced 64.01%	27,862 $37,000
Q2 2023 Nov 13, 2023	SELL	$2.07 - $2.92 $22,749 - $32,090	-10,990 Reduced 12.43%	77,406 $166,000
Q1 2023 May 11, 2023	SELL	$2.81 - $6.71 $2,936 - $7,011	-1,045 Reduced 1.17%	88,396 $257,000
Q4 2022 Feb 13, 2023	SELL	$3.44 - $6.87 $32,979 - $65,862	-9,587 Reduced 9.68%	89,441 $614,000

Q3 2022 Nov 10, 2022	BUY	$2.35 - $4.66 $139,237 - $276,105	59,250 Added 148.95%	99,028 $314,000
Q2 2022 Aug 08, 2022	BUY	$2.09 - $3.71 $8,485 - $15,062	4,060 Added 11.37%	39,778 $128,000
Q1 2022 Apr 28, 2022	BUY	$2.84 - $4.52 $28,456 - $45,290	10,020 Added 38.99%	35,718 $108,000
Q4 2021 Feb 11, 2022	SELL	$3.87 - $6.59 $11,892 - $20,251	-3,073 Reduced 10.68%	25,698 $115,000
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $113,160 - $282,719	18,193 Added 171.99%	28,771 $189,000
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $107,366 - $182,470	10,578 New	10,578 $153,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.